© 2005 Oxford University Press
ARTICLE |
Flexible Sigmoidoscopy in the PLCO Cancer Screening Trial: Results From the Baseline Screening Examination of a Randomized Trial
for the PLCO Project Team
Affiliations of authors: University of Pittsburgh Cancer Institute, Pittsburgh, PA (JLW, RES); Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (PFP, PCP, JKG); Henry Ford Hospital, Detroit, MI (RSB); University of Minnesota, Minneapolis, MN (TC); Westat, Rockville, MD (SY); Information Management Services, Inc., Rockville, MD (JHA)
Correspondence to: Joel L. Weissfeld, MD, MPH, UPMC Cancer Pavilion (POB II), 3rd Floor Centre Medical Building, 5150 Centre Avenue, Pittsburgh, PA 15232 (e-mail: jwepid{at}pitt.edu).
Background: The Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial is a randomized clinical trial to test the effectiveness of cancer screening, including the effect of flexible sigmoidoscopy screening on colorectal cancer mortality. Here we report findings from the baseline screening flexible sigmoidoscopy examination. Methods: Analyses included 77 465 men and women aged 5574 years who were enrolled at 10 screening centers. The trial administered baseline risk factor questionnaires, offered 60-cm flexible sigmoidoscopy examinations, referred patients with screen-detected colorectal polyps or masses to personal physicians, and tracked subjects with polyps or masses to determine results from diagnostic follow-up. CochranMantelHaenszel statistics and logistic regression were used to test for differences in proportions according to sex and age. Results: A total of 64 658 subjects (83.5%) underwent screening flexible sigmoidoscopy, and at least one polyp or mass was identified in 15 150 subjects (23.4%). Of these, 74.2% received follow-up lower endoscopic procedures. Follow-up lower endoscopy was more frequent in subjects with at least one larger (
0.5 cm) polyp or mass (86.0% [95% confidence interval {CI} = 84.6% to 87.4%] and 81.0% [95% CI = 79.8% to 82.2%] in women and men, respectively) than in those with a smaller (<0.5 cm) polyp or mass (69.1% [95% CI = 67.5% to 70.6%] and 65.4% [95% CI = 64.1% to 66.7%] in women and men, respectively). The yields per 1000 screened, depending on 5-year age group, were as follows: for colorectal cancer, 1.12.5 in women and 2.45.6 in men; for advanced adenoma, 18.030.4 in women and 36.149.1 in men; and for colorectal cancer or any adenoma, 50.679.6 in women and 101.9128.6 in men. Approximately 77% (130/169) of the colorectal adenocarcinoma patients were stage I or II at diagnosis. Conclusions: Acceptance of screening flexible sigmoidoscopy was high. Diagnostic follow-up varied according to polyp size, yet cancer or adenoma detection rates met expectations.
This article has been cited by other articles:
![]() |
E. P. Whitlock, J. S. Lin, E. Liles, T. L. Beil, and R. Fu Screening for Colorectal Cancer: A Targeted, Updated Systematic Review for the U.S. Preventive Services Task Force Ann Intern Med, October 6, 2008; (2008) 0000605-200811040-00245. [Abstract] [Full Text] |
||||
![]() |
B. Levin, D. A. Lieberman, B. McFarland, R. A. Smith, D. Brooks, K. S. Andrews, C. Dash, F. M. Giardiello, S. Glick, T. R. Levin, et al. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology CA Cancer J Clin, May 1, 2008; 58(3): 130 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Ravenel, P. Costello, and G. A. Silvestri Screening for Lung Cancer Am. J. Roentgenol., March 1, 2008; 190(3): 755 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E Millen, A. F Subar, B. I Graubard, U. Peters, R. B Hayes, J. L Weissfeld, L. A Yokochi, R. G Ziegler, and for the Prostate, Lung, Colorectal, and Ovarian (P Fruit and vegetable intake and prevalence of colorectal adenoma in a cancer screening trial Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1754 - 1764. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Denis, M. Ruetsch, P. Strentz, J. Y. Vogel, F. Guth, J. M. Boyaval, X. Pagnon, J. F. Ebelin, I. Gendre, and P. Perrin Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test Gut, November 1, 2007; 56(11): 1579 - 1584. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Berndt, W.-Y. Huang, N. Chatterjee, M. Yeager, R. Welch, S. J. Chanock, J. L. Weissfeld, R. E. Schoen, and R. B. Hayes Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma Carcinogenesis, September 1, 2007; 28(9): 1965 - 1970. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Kirsh, U. Peters, S. T. Mayne, A. F. Subar, N. Chatterjee, C. C. Johnson, and R. B. Hayes Prospective Study of Fruit and Vegetable Intake and Risk of Prostate Cancer J Natl Cancer Inst, August 1, 2007; 99(15): 1200 - 1209. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Loewen, N. Natarajan, D. Tan, E. Nava, D. Klippenstein, M. Mahoney, M. Cummings, and M. Reid Autofluorescence bronchoscopy for lung cancer surveillance based on risk assessment Thorax, April 1, 2007; 62(4): 335 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Mai, J. Sullivan-Halley, G. Ursin, D. O. Stram, D. Deapen, D. Villaluna, P. L. Horn-Ross, C. A. Clarke, P. Reynolds, R. K. Ross, et al. Physical Activity and Colon Cancer Risk among Women in the California Teachers Study Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 517 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Brenner, J. Chang-Claude, C. M. Seiler, T. Sturmer, and M. Hoffmeister Potential for Colorectal Cancer Prevention of Sigmoidoscopy Versus Colonoscopy: Population-Based Case Control Study Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 494 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Bini, J. Park, and F. Francois Use of Flexible Sigmoidoscopy to Screen for Colorectal Cancer in HIV-Infected Patients 50 Years of Age and Older. Arch Intern Med, August 14, 2006; 166(15): 1626 - 1631. [Abstract] [Full Text] [PDF] |
||||









